European country suggests sex offender measure
Reports have confirmed that the British Ministry of Justice plans to expand the use of medications that help control sexual desire among sex offenders. Starting from December 2028, it is expected that approximately 3,750 prisoners out of 15,000 in England and Wales who experience persistent and intense sexual urges will receive these medications. The program, called "Medication Management Pathway for Addressing Problematic Sexual Arousal" (MMPSA), is overseen by a team of experts and aims to reduce the risk of reoffending, with a particular focus on the most serious sex offenders, such as those involved in exploiting children. While data indicates a decrease in reoffense rates among these prisoners to 11.7%, the program faces criticism regarding its effectiveness and health impacts. Experts warn of the dangers associated with mandatory treatment and emphasize the importance of voluntary participation to ensure the therapy’s effectiveness and maintain prisoners’ trust. Meanwhile, the government is considering the possibility of wider implementation of the treatment after assessing the initial results.
Notice: This Is an AI-Generated Summary
Comments (0)